Gene Polymorphisms Influencing Steroid Synthesis and Action

Sponsor
University Hospital Schleswig-Holstein (Other)
Overall Status
Withdrawn
CT.gov ID
NCT00485186
Collaborator
(none)
0
72

Study Details

Study Description

Brief Summary

The extend of steroid biosynthesis and action is mainly dependent on underlying genetic polymorphisms and gene mutations. These sequence variations in multiple genes involved in steroid biosynthesis and action cause different diseases (for example congenital adrenal hyperplasia or disorders of sex development). In addition, sequence variations in several other genes may influence the severity of a genetically caused disease of steroid biosynthesis or action. By this, the differences in an observed phenotype may be explained. Within the study all genes necessary for adrenal and gonadal steroid biosynthesis and several genes which are known to influence the action of steroid hormones will be analysed in patients with congenital disorders of adrenal and gonadal steroid biosynthesis, disorders of steroid action and disorders of sex development. The primary aim is to set up a correlation of the disease phenotype with the different genotypes detected.

Study Design

Study Type:
Observational
Actual Enrollment :
0 participants
Observational Model:
Family-Based
Time Perspective:
Prospective
Official Title:
Investigation of Gene Polymorphisms Influencing Steroid Synthesis and Action in Patients With Deficient Steroid Biosynthesis and Disorders of Sex Development
Study Start Date :
Jun 1, 2007
Actual Primary Completion Date :
Jun 1, 2013
Actual Study Completion Date :
Jun 1, 2013

Arms and Interventions

Arm Intervention/Treatment
1

2

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Disorders of Sex Development

    • Congenital Adrenal Hyperplasia

    • Congenital Adrenal Hypoplasia

    • Adrenal Insufficiency

    • Mineralocorticoid Deficiency

    • Salt-loss

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • University Hospital Schleswig-Holstein

    Investigators

    • Study Chair: Paul-Martin Holterhus, MD, University Hospital Schleswig-Holstein
    • Principal Investigator: Felix G Riepe, MD, University Hospital Schleswig-Holstein

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Felix Riepe, Prof. Dr., University Hospital Schleswig-Holstein
    ClinicalTrials.gov Identifier:
    NCT00485186
    Other Study ID Numbers:
    • D429/05
    First Posted:
    Jun 12, 2007
    Last Update Posted:
    Sep 5, 2013
    Last Verified:
    Sep 1, 2013

    Study Results

    No Results Posted as of Sep 5, 2013